Race/Ethnicity in Atrial Fibrillation Stroke: Epidemiology and Pharmacotherapy

The authors acknowledge the writing and editorial assistance of Rosemary Perkins of Envision Pharma Group, whose services were funded by Boehringer Ingelheim Pharmaceuticals, Inc. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE), were fully responsible for all content and editorial decisions, and were involved in at all stages of manuscript development. The authors received no compensation related to the development of the manuscript.